Mixed community-acquired pneumonia in hospitalised patients

被引:66
|
作者
de Roux, A
Ewig, S
García, E
Marcos, MA
Mensa, J
Lode, H
Torres, A
机构
[1] Hosp Clin Barcelona, Dept Pulm, Serv Malad Infect, E-08036 Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Pulm, Microbiol Serv, E-08036 Barcelona, Spain
[3] Univ Barcelona, Fac Med, Serv Pneumol Allergia Resp, Inst Clin Torax,Inst Invest Biomed August Pi Suny, Barcelona 7, Spain
[4] Augusta Kranken Anstalt Bochum, Klin Pneumol, Bochum, Germany
[5] Abt Pneumol, Lungenklin Heckenshorn, Berlin, Germany
关键词
community-acquired pneumonia; hospitalisation; mixed pneumonia;
D O I
10.1183/09031936.06.00058605
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The role of mixed community-acquired pneumonia (CAP) is controversial. The aim of the present study was to determine the incidence, principal microbial patterns, clinical predictors and course of mixed CAP. The current study included 1,511 consecutive hospitalised patients with CAP. Of these, 610 (40%) patients had an established aetiology. One pathogen was demonstrated in 528 patients and 82 (13%) patients had mixed pneumonia. Cases including CAP, by a pyogenic bacteria and a complete paired serology for "atypicals", revealed that 82 (13%) patients had definite single pyogenic pneumonia and 28 patients (5%) had mixed pyogenic pneumonia. In patients with mixed CAP, Streptococcus pneumoniae was the most prevalent microorganism (44 out of 82; 54%). The most frequent combination was S. pneurnoniae with Haemophilus influenzae (17 out of 82; 21%). Influenza virus A and S. pneumoniae (five out of 28; 18%) was the most frequent association in the mixed pyogenic pneumonia group. No clinical predictors for mixed pneumonias could be identified. Patients with mixed pyogenic pneumonia more frequently developed shock when compared with patients with single pyogenic pneumonia (18 versus 4%). In conclusion, mixed pneumonia occurs in > 10% of cases with community-acquired pneumonia requiring hospitalisation.
引用
收藏
页码:795 / 800
页数:6
相关论文
共 50 条
  • [31] Association between body mass index and mortality in hospitalised patients with community-acquired pneumonia
    Kim, Richard Y.
    Glick, Connor
    Furmanek, Stephen
    Ramirez, Julio A.
    Cavallazzi, Rodrigo
    ERJ OPEN RESEARCH, 2021, 7 (01)
  • [32] Discharge disposition as an independent predictor of readmission among patients hospitalised for community-acquired pneumonia
    Dong, Tien
    Cursio, John F.
    Qadir, Samira
    Lindenauer, Peter K.
    Ruhnke, Gregory W.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (3-4)
  • [33] Community-acquired pneumonia in older patients
    Janssens, JP
    Gauthey, L
    Herrmann, F
    Tkatch, L
    Michel, JP
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (05) : 539 - 544
  • [34] Community-acquired Pneumonia - Common for the Patients
    Bauer, T. T.
    Lorenz, J.
    PNEUMOLOGE, 2015, 12 (02): : 99 - 100
  • [35] Community-acquired pneumonia in elderly patients
    Niederman, MS
    Ahmed, QAA
    CLINICS IN GERIATRIC MEDICINE, 2003, 19 (01) : 101 - +
  • [36] Community-acquired pneumonia in patients with HIV
    Cunha, BA
    DRUGS OF TODAY, 1998, 34 (09): : 739 - 745
  • [37] Hospitalization of patients with community-acquired pneumonia
    Ordóñez, MAG
    González, BP
    ARCHIVOS DE BRONCONEUMOLOGIA, 2003, 39 (05): : 240 - 241
  • [38] A follow-up study of children hospitalised with community-acquired pneumonia
    Eastham, K. M.
    Hammal, D. M.
    Parker, L.
    Spencer, D. A.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2008, 93 (09) : 755 - 759
  • [39] Trovafloxacin vs Ceftriaxone/Cefpodoxime ± Erythromycin in Hospitalised Community-Acquired Pneumonia
    D. Williams Hopkins
    R. Daniel
    Drugs, 1999, 58 : 318 - 319
  • [40] Trovafloxacin vs ceftriaxone/cefpodoxime ± erythromycin in hospitalised community-acquired pneumonia
    Hopkins, DW
    Daniel, R
    DRUGS, 1999, 58 (Suppl 2) : 318 - 319